Font Size: a A A
Keyword [TACE]
Result: 141 - 160 | Page: 8 of 10
141. Comparative Study Of Efficacies Of Tace Combined With125I Seed And Of Sample TACE In Treatment Of PLC
142. Clinical Application Of Gelfoam Particles With Iodine Oil Emulsion In TACE To The Treatment Of Huge Hepatic Carcinoma
143. The Study On MVI As An Indication Of Postoperative Adjuvant TACE Of HCC
144. Hepatocellular Carcinoma Treated With Transcatheter Arterialchemoembolization: A New CT Typing System Correlated With The Response
145. Symptoms, Symptom Clusters And Quality Of Life In Patients With PLC Undergoing TACE: A Prospective, Longitudinal Study
146. Evaluation Of The HCC CT Classification In Liver Reserve Function Before TACE
147. Tace And Pei For Unresectable Hepatocellular Carcinoma：a Systematic Review And Meta—Analysis
148. Therapeutic Effect Of Transcatheter Arterial Chemoembolization (TACE) Prior To High-intensity Focused Ultrasound (HIFU) For Patients With Advanced Hepatocellular Carcinoma80Cases
149. The Correlation Of TCM Syndrome Of Primary Liver Carcinoma And The Change Of Liver Function Before And After TACE
150. Clinical Observation On Combined Therapy Of Transcatheter Arterial Chemoembolization(TACE) And Three-dimensional Conformal Radiotherapy(3D-CRT) For Treatment Of Primary Hepatocellular Carcinoma(PHC)
151. The Application Of STK1and AFP In Therapeutic Monitoring Of PLC Pre And Post TACE
152. Action And Significance Of TACE On Serum Levels Of CTGF And VEGF In HCC Patients.
153. The Curative Effect Contrast Between Hepatic Resection And Tace For Hepatocellular Carcinoma BCLC Stage B
154. The Expression Of Foxp3、IL-2、IL-10and TGF-β1in Hepatocellular Carcinoma And TACE Of Its Expression Effect
155. The Study Of Radiotherapy For Liver Cancer:Sorafenib Maintenance Following Radiotherapy And The Determination Of Internal Target Volume With4DCT
156. The Impact Of Transcatheter Arterial Chemoembolization On Hepatitis B Virus Reactivation And The Effect Of Lamivudine On The Hepatitis B Virus Reactivation
157. Changes And Significance Of Serum VEGF、CTGF、HIF-1α And OPN Before And After TACE In Primary Hepatocellular Carcinoma Patients
158. The Dynamic Changes Of Serum HIF-1a, VEGF, OPN, CTGF Levels With Treatment Of TACE Combined With Endostar In HCC Patients
159. Evidence Based Nursing Of Likating Combined With TACE In Treatment Of Liver Cancer Patients With Anxiety And Quality Of Life Effect
160. Cytokine Induced Killer Cells Combined With TACE In The Treatment Of Primary Hepatocellular Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to